名称 | SF1670 |
描述 | SF1670 (PTPase CD45 Inhibitor) is a specific PTEN inhibitor with IC50 of 2 μM. |
细胞实验 | Cells are plated into 96-well plates in RPMI 1640 medium supplemented with 10% FBS and incubated overnight at 37°C. in an incubator containing an atmosphere of 5% CO2. The following day, the medium is replaced and cells are starved by placing in 100 uL of serum-free medium for 3 hours. Serially diluted test compounds are added to the wells and incubated with the cells for 2 hours at 37°C. Compounds are tested in a range from 1 mM to 0.1 nM depending on solubility. MTT is added to the wells at a final concentration of 5 μg/ml and incubated with the cells for 3 more hours. At the end of the incubation, the medium is aspirated and the MTT stain in the cells is dissolved by the addition of 100 μL DMSO. Optical density of each well is then measured at 570 nm using a SpectroMax Plus spectrophotometric plate reader. The IC50 determination from the data was made using Prism software.(Only for Reference) |
激酶实验 | PTEN Inhibition Assay: To determine the dose response of potential PTEN inhibitors, doses of test compounds ranging from 1 nM to 250 uM (final reaction mix concentrations) are evaluated in the general PTEN inhibition assay. To obtain performed IC50 data, two separate rounds of the dose response assay are performed. In the first round, PTEN activity is tested in the presence of inhibitor at 10 fold serial dilutions ranging from 1 nM to 250 uM. Once the concentration range is determined, at which PTEN activity changes dramatically, two additional concentration data points within this range are added and the PTEN inhibition assay is then rerun for the second round. The PTEN inhibition IC50 is presented as the inhibitor concentration at which 50% of the PTEN activity. When the assay was run on multiple occasions and gave slightly different IC50 then those are reported as a range of IC50 found. |
体外活性 | SF1670在HBEC、PC-3、H1299细胞中表现出强烈的细胞毒性,其半抑制浓度(IC50)分别为5 μM、10 μM和44 μM。在小鼠主动脉环Matrigel血管生成模型中,SF1670促进血管生成过程。[1] SF1670增强中性粒细胞对趋化因子诱导的PtdIns(3,4,5)P3信号传导,提高中性粒细胞功能。[2] |
体内活性 | SF1670 (500 nM i.v.)的预处理能增强中性粒细胞减少症小鼠在腹膜炎和细菌性肺炎中的细菌杀伤能力,并降低与中性粒细胞减少相关的肺炎死亡率。[2] |
存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 30.7 mg/mL (100 mM)
|
关键字 | SF1670 | SF 1670 | inhibit | Autophagy | MMAC1 | Inhibitor | Phosphatase and tensin homolog | SF-1670 | Phosphatase | PTEN |
相关产品 | Guanidine hydrochloride | Naringin | Stearic acid | Valproic Acid | Taurine | Gefitinib | Aceglutamide | Hydroxychloroquine | Curcumin | Stavudine | Paeonol | Sodium 4-phenylbutyrate |
相关库 | 抑制剂库 | 经典已知活性库 | 抗癌化合物库 | 已知活性化合物库 | 抗癌细胞代谢库 | 自噬库 | 抗衰老化合物库 | 抗肝癌化合物库 | 抗氧化化合物库 | PI3K/Akt/mTOR 化合物库 |